How can we ensure all South Americans will have access to the best treatments? This is the fundamental question of the third issue of Inspira 2030, our maganize on the Sustainable Development Goals (#SDGs).

In order to answer this question, we interviewed the Director of UNITAID Celso Amorim, Michelle Childs of the Drugs for Neglected Diseases initiative (DNDi), the ISAGS former Director José Gomes Temporão and Colombian researcher Claudia Vaca. So as to hint the impact of the UNASUR Medicine Price Database, we talked to Santiago Vázquez, who devised a similar tool in Ecuatorian SERCOP. In addition, we tell you all about the Compulsory Licensing of Efavirenz in Brazil and the dilemmas surrounding paediatric medicines.

Have a look at the digital version at http://bit.ly/Inspira2030Medicines or download the PDF at http://bit.ly/Inspira2030MedicinesPDF

INSPIRA 2030 is a new bimonthly publication of ISAGS that aims to give a contribution to the debate on the Sustainable Development Goals (SDG) with opinions and experiences ("inspirations") of South America's authorities and reseachers.

The South American Institute of Government in Health (ISAGS) is an intergovernmental public organism associated to the Health Council of the Union of South American Nations. As a centre of high studies and debate of public policies, its actions contribute for the development of governance and leadership in health in South America.